Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abciximab
advances in neurology
adverse drug reaction
air transport
algorithm
anatomy of
aneurysm, intracranial
aneurysm, intracranial, treatment of
angiography, cerebral
angiography, neurologic complications with
angiography, posterior fossa
anterior cerebral artery
anterior cerebral artery territory infarction
anterior cerebral artery, emboli to
anterior cerebral artery, occlusion of
anterior temporal branch of posterior cerebral artery
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
antiphospholipid antibodies
arterial dissection
arterial dissection, basilar
arterial dissection, vertebral
arterial perforation
Asians
aspirin
atrial fibrillation
baroreceptors
BASICS trial
basilar artery
basilar artery occlusion
basilar artery stenosis
BEST trial
biologic markers
biotinidase deficiency
blacks
blood brain barrier
blood pressure
blood pressure after stroke
brainstem, infarction of
brainstem, ischemia
brainstem, lesion of
bridge therapy
call 911
cardiac catheterization, neurologic complications
cardiac surgery
cardiovascular disease
carotid artery
carotid artery atherosclerosis
carotid artery disease
carotid artery occlusion, intracranial
carotid artery occlusion, neck
carotid artery stenosis
carotid artery stenosis, preocclusive
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, angiography, false negative
CAT scan, angiography, false positive
CAT scan, angiography, source images
CAT scan, contrast enhanced
CAT scan, contrast extravasation
CAT scan, dense artery sign
CAT scan, disappearing lesion on
CAT scan, false negative
CAT scan, false positive
CAT scan, helical
CAT scan, mismatch between perfusion/diffusion
CAT scan, perfusion
CAT scan, venography
central artery of Percheron
central retinal artery occlusion
central venous catheter
cerebellar infarction
cerebral edema
cerebral embolism
cerebral embolism, cardiac origin
cerebral embolism, mechanical extraction
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebral veins
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, arterial occlusion, location
cerebrovascular accident, awakening with
cerebrovascular accident, bilateral
cerebrovascular accident, circadian rhythm
cerebrovascular accident, complications with
cerebrovascular accident, cost of
cerebrovascular accident, etiology
cerebrovascular accident, infancy and childhood
cerebrovascular accident, in-hospital
cerebrovascular accident, location of
cerebrovascular accident, multiple
cerebrovascular accident, pathophysiology
cerebrovascular accident, postoperative
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, racial differences
cerebrovascular accident, recurrent
cerebrovascular accident, seizure with
cerebrovascular accident, severity
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, thromobolytic agents in treatment, early dramatic recovery
cerebrovascular accident, time to treatment
cerebrovascular accident, vascular territory involved
cerebrovascular accident, volume
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, treatment of
chemotherapy, intra-arterial
children
CHOICE trial
circle of Willis
Clinical Pathologic Conference(C.P.C.)
clot retrieval
cocaine
coma
Community hospital
comorbidities
complications
controversies in neurology
coronary artery bypass
cortical vein thrombosis
cost
cost effectiveness
coumarin
coumarin, stopping treatment
craniectomy, decompressive
craniotomy
critical care unit
critical pathway
D-dimer
dehydration
delay in diagnosis
dementia
dense basilar artery sign
dense posterior cerebral artery sign
diabetes insipidus
diplopia
disability, neurological
dizziness
drop attacks
dural sinus thrombosis
edema, facial
efficacy
embolism
embolism, vertebral-basilar artery
embolization, therapeutic
emergencies, neurologic
emergency medical technicians
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endovascular therapy
endovascular therapy, time window
epidemiology of neurology
evidence-based research
Factor V Leiden
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic agents, intra-venous local infusion
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
fresh frozen plasma
gadolinium
gaze palsy
glucose level, serum
head injury
headache
headache, severe
heart valve surgery
hematoma, intracerebral
hemianopia
hemianopia, homonymous
hemiparesis
hemiplegia
hemorrhagic diathesis
heparin
herniation syndromes, intracranial
hippocampal infarction
hydrocephalus
hyperintense vessel sign
hyperperfusion syndrome
hypertension
iatrogenic neurologic disorders
incidence
infarct core
in-hospital
institutional review board
internal carotid artery
internal cerebral vein
internet
intracerebral hemorrhage
intracerebral hemorrhage, progression of
intracerebral hemorrhage, small
intracranial hemorrhage
intracranial pressure, increased
intubation
ischemic penumbra
level of consciousness, decreased
lithium
lumbar puncture, complications of
malformation, vascular
malformation, vascular, cerebral
mastoiditis
mental status, abnormal
MERCI trial
middle cerebral artery
middle cerebral artery territory infarction
middle cerebral artery territory infarction, malignant
middle cerebral artery, emboli to
middle cerebral artery, occlusion of
misdiagnosis
mortality
MR CLEAN
MRI
MRI, abnormal
MRI, ADC maps
MRI, angiography
MRI, angiography, contrast enhanced
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, early changes in CVA
MRI, emergent
MRI, false negative
MRI, gradient-echo
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRI, serial
MRI, venography
multimodal neuroimaging
nerve block
neuritis, causes of
neurologic complications of, surgery
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic examination, focal
neurologic recovery
neurologic signs
neurologic symptoms
neuroprotective agents
neuroradiology, interventional
NIH stroke scale
nystagmus
occipital lobe, infarction
old age, neurology of
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
otitis, neurologic complications with
outcome research
pitfalls
platelet inhibiting drugs
platelet inhibiting drugs, combined
posterior cerebral artery
posterior cerebral artery embolism
posterior cerebral artery occlusion
posterior cerebral artery territory infarction
posterior cerebral artery, fetal type
posterior circulation stroke
postoperative neurologic complications
postpartum
practice guidelines
pregnancy, neurologic complications in
prethrombotic state
prognosis
protein C deficiency
protein S deficiency
protocol violations
recanalization, arterial
recanalization, venous
reperfusion
Retriever Device
REVASCAT trials
revascularization, surgical
review article
risk factors
risk-benefit assessment
safety
screening
seizure
seizure, acute symptomatic
seizure, complications following
seizure, prevention of
single photon emission computed tomography
solitaire device
stent, carotid artery
stent, vertebral artery
streptokinase
stroke center
stroke disability scale
stroke protocol
stroke team
stroke unit
stroke unit, mobile
subarachnoid hemorrhage
subclavian vein catheterization
superior sagittal sinus thrombosis
SWIFT PRIME Trials
T lesion of MCA-ICA
telemedicine
teleneurology
teleradiology
thalamus, infarction of
thalamus, infarction, bilateral
thalamus, lesion of
thalamus, lesion of-bilateral
thrombectomy
thrombin inhibitor
thrombolysis, mechanical
time is brain
tissue plasminogen activator, intravenous
top of the basilar syndrome
transluminal angioplasty, basilar artery
transluminal angioplasty, carotid artery
transluminal angioplasty, intracranial
transluminal angioplasty, intracranial-indications for
transluminal angioplasty, middle cerebral artery
transluminal angioplasty, vertebral artery
transport of patient
treatment of neurologic disorder
trial design
uncal herniation
unconsciousness
unconsciousness, transient
urokinase
vein of Galen
venogram, cerebral
vertebral artery occlusion
vertebral artery stenosis
vertebral-basilar artery, intraluminal clot
vertebral-basilar insufficiency
vertigo
vestibular function, tests of
visual field defect
visual loss
visual loss, sudden
visual loss, sudden-unilateral
vitamin K
workup
Showing articles 550 to 600 of 3600 << Previous Next >>

Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001

Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001

Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated with Symptomatic Intracerebral Hemorrhage
Stroke 32:12-16, Lopez-Yunez,A.M.,et al, 2001

Early Stroke Treatment Associated with Better Outcome
Neurol 55:1649-1655, Marler,J.R.,et al, 2000

Effect of intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography
Stroke 31:2912-2919, The National Institute of Neurological Disorders a, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000

Can Emergency Department Physicians Safely and Effectively Initiate Thrombolysis for Acute Ischemic Stroke?
Neurol 55:1801-1805, Akins,P.T.,et al, 2000

Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000

Treatment of Intraventricular Hemorrhage with Urokinase
Stroke 31:841-847, Naff,N.J.,et al, 2000

Stereotactic Computed Tomographic-Guided Aspiration and Thrombolysis of Intracerebral Hematoma
Stroke 31:834-840, Montes,J.M.,et al, 2000

Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000

Intracranial Hemorrhage Associated With Thrombolytic Therapy for Eldery Patients With Acute Myocardial Infarction
Stroke 31:1802-1811, Brass,L.M. et al, 2000

Orolingual Angioneurotic Edema Following Therapy of Acute Ischemic Stroke with Alteplase
Neurol 55:599-600, Rudolf,J. et al, 2000

Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke With Diffusion and Perfusion MRI
Stroke 31:1318-1328, Schellinger,P.D.,et al, 2000

Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000

Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000

Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000

Transcranial Doppler Ultrasound Criteria for Recanalization After Thrombolysis for Middle Cerebral Artery Stroke
Stroke 31:1128-1132, Burgin,W.S.,et al, 2000

Comparison of Diffusion-Weighted MRI and CT in Acute Stroke
Neurol 54:1557-1561,1548,1549,1552, Lansberg,M.G.,et al, 2000

Intravenous tPA in Acute Ischemic Stroke Related to Internal Carotid Artery Dissection
Neurol 54:2159-2161, Derex,L.,et al, 2000

Identification of lacunar Infarcts Before Thrombolysis in the ECASS I Study
Neurol 54:684-688, Toni,D.,et al, 2000

rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000

Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000

Stroke Treatment with Tissue Plasminogen Activator in the Setting of Aortic Dissection
Neurol 54:1010, Fessler,A.J. & Alberts,M.J., 2000

Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000

Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000

Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000

CT Angiography and Doppler Sonography for Emergency Assessment in Acute Basilar Artery Ischemia
Stroke 30:606-612, Brandt,T.,et al, 1999

Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999

Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Stroke 30:389-392, Marks,M.P.,et al, 1999

"Telestroke",The Application of Telemedicine for Stroke
Stroke 30:464-469, Levine,S.R.&Gorman,M., 1999

Cerebral Venous Thrombosis,Nothing,Heparin,or Local Thrombolysis?
Stroke 30:481-483, Bousser,M-G, 1999

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999

Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999

MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999

Applications of Diffusion-Perfusion Magnetic Resonance Imaging in Acute Ischemic Stroke
Neurol 52:1750-1756,1733, Fisher,M.&Albers,G.W., 1999

Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999

Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999

Evaluation of Early Reperfusion and IV tPA Therapy Using Diffuion- and Perfusion-Weighted MRI
Neurol 52:1792-1798,1733, Marks,M.P.,et al, 1999

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999

Association of Hyperdense Middle Cerebral Artery Sign with Clinical Outcome in Patients Treated with Tissue Plasminogen Activator
Stroke 30:769-772, Manelfe,C.,et al, 1999

Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999

Evidence of Anaphylaxy after Alteplase Infusion
Stroke 30:1142-1143, Rudolf,J.,et al, 1999

Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction
Ann Int Med 129:597-604, Gurwitz,J.H.,et al, 1998

The Predictive Value of Early CT and Angiography for Fatal Hemispheric Swelling in Acute Stroke
AJNR 19:839-846, 9931998., Kucinski,T.,et al, 1998

Regional Ischemic & Ischemic Injury in Pts with Acute Mid Cereb Art Stroke as Defined by Early Diffusion-Wt & Perfusion-Wt MRI
Stroke 29:939-943, Rordorf,G.,et al, 1998

Randomised Double-Blind Placebo-Controlled Trial of Thrombolytic Therapy with Intravenous Alteplase in Acute Ischaemic Stroke (ECASS II)
Lancet 352:1245-1251,1238, Hacke,W.,et al, 1998

Thrombolysis with Intravenous rtPA in a Series of 100 Cases of Acute Carotid Territory Stroke,Determination of Etiological,Topographic,and Radiological Outcome Factors
Stroke 29:2529-2540, Trouillas,P.,et al, 1998



Showing articles 550 to 600 of 3600 << Previous Next >>